A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer
- 1 February 2007
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 106 (2) , 191-203
- https://doi.org/10.1007/s10549-007-9494-y
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Stilbene-Based Inhibitors of Estrone Sulfatase with a Dual Mode of Action in Human Breast Cancer CellsArchiv der Pharmazie, 2004
- Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens.Endocrine-Related Cancer, 2003
- Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cellsOncogene, 2002
- Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells☆Steroids, 2000
- Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral applicationThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growthNature, 1994
- Importance of estrogen sulfates in breast cancerJournal of Steroid Biochemistry, 1989
- Subcellular compartmentalization of estrogen receptors in human breast cancer cellsExperimental Cell Research, 1980
- Estrone Sulfate: Production Rate and Metabolism in ManJournal of Clinical Investigation, 1972